Journals / The Anatolian Journal of Cardiology / 2017 / Cilt: 18 - Sayı: 1

Evaluation of the ambulatory arterial stiffness index in lead-exposed workers

Pages
10–14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increased AASI may be considered an early sign of arterial involvement in case of lead exposure

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Lead exposure has been associated with various cardiovascular disorders.
📊
Key Findings & Data:It may also cause increased inflammation and fibrosis in the arterial system resulting in an increase in arterial stiffness.
💡
Conclusion & Impact:Increased AASI may be considered an early sign of arterial involvement in case of lead exposure
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Lead exposure has been associated with various cardiovascular disorders. It may also cause increased inflammation and fibrosis in the arterial system resulting in an increase in arterial stiffness. In this study, the ambulatory arterial stiffness index (AASI), which is a technique that measures arterial stiffness, was evaluated in occupationally lead-exposed workers.Methods: In this cross-sectional study, 68 lead-exposed workers without known cardiovascular risk factors and 68 healthy subjects were evaluated according to the 24-hour ambulatory blood pressure monitorization (ABPM) profiles and blood and 24-hour urine lead levels. A regression slope of diastolic over systolic blood pressure (BP) was computed in each participant. AASI was defined as 1 minus the regression slope.Results: There were no significant differences in terms of baseline demographic, clinical, echocardiographic characteristics, and ABPM profiles between the groups. In lead-exposed workers, the mean age was 34.7±8.1 years, and the median blood and urine lead levels were 40.5 μg/dL and 34.9 μg/L, respectively. AASI was 0.42±0.10 in lead-exposed workers and 0.37±0.10 in control subjects (p=0.007). In correlation analysis, AASI was correlated with both blood (r=0.417, p<0.001) and urine lead (r=0.242, p=0.047) levels. In regression analysis, blood lead level was found to be associated with AASI (β=0.086, p<0.001).Conclusion: AASI, which is an indicator of arterial stiffness, was found to be higher in lead-exposed workers than in healthy individuals. Increased AASI may be considered an early sign of arterial involvement in case of lead exposure

🔖

Cite This Article

KARAKULAK, U. N., YILMAZ, Ö. H., TUTKUN, E., ATEŞ, İ., BAL, C., GÜNDÜZÖZ, M. (2017). Evaluation of the ambulatory arterial stiffness index in lead-exposed workers. The Anatolian Journal of Cardiology, Cilt: 18 - Sayı: 1, 10–14. https://ajindex.com/articles/365839

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Jain NB, Potula V, Schwartz J, Vokonas PS, Sparrow D, Wright RO, et al. Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men: the VA Normative Aging Study. En- viron Health Perspect 2007; 115: 871-5.
  2. Lee TH, Tseng MC, Chen CJ, Lin JL. Association of high body lead store with severe intracranial carotid atherosclerosis. Neurotoxi- cology 2009; 30: 876-80.
  3. Chen CC, Yen HW, Lo YH, Chu YH, Chiu YW, Chuang HY. The associ- ation of prolonged QT interval on electrocardiography and chronic lead exposure. J Occup Environ Med 2013; 55: 614-9.
  4. Lu Y, Liu X, Deng Q, Duan Y, Dai H, Li Y, et al. Continuous lead expo- sure increases blood pressure but does not alter kidney function in adults 20-44 years of age in a lead-polluted region of China. Kidney Blood Press Res 2015; 40: 207-14. Vaziri ND. Mechanisms of lead-induced hypertension and cardio- vascular disease. Am J Physiol Heart Circ Physiol 2008; 295: 454-65.
  5. Dursun N, Arifoğlu C, Süer C, Keskinol L. Blood pressure relation- ship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels. Biol Trace Elem Res 2005; 104: 141-9.
  6. Park S, Lakatta EG. Role of inflammation in the pathogenesis of ar- terial stiffness. Yonsei Med J 2012; 53: 258-61.
  7. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-605.
  8. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovas- cular events and all-cause mortality with arterial stiffness: a syste- matic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-27.
  9. Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S, et al. Am- bulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 2006; 47: 365- 70. Kikuya M, Staessen JA, Ohkubo T, Thijs L, Metoki H, Asayama K, et al. Ambulatory arterial stiffness index and 24-hour ambula- tory pulse pressure as predictors of mortality in Ohasama, Japan. Stroke 2007; 38: 1161-6.
  10. Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T, et al. Ambula- tory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension 2006; 47: 359-64.
  11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pel- likka PA, et al. Recommendations for chamber quantification: a re- port from the American Society of Echocardiogra